Skip to content
IASLC RET NSCLC episode artwork

Feb 22, 2023 34 min

IASLC RET NSCLC

from Lung Cancer Considered Hosted by IASLC

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about NSCLC with RET rearrangements, including diagnosis, treatment, and new exciting research coming down the pipeline. Podcast guests are: Dr. Justin Gainor, the Director of the Center for Thoracic Cancers at the Massachusetts General Hospital (MGH), Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies, and Co-Leader of the SU2C Lung Cancer Dream Team. His major research interests have focused on targeted therapy and immunotherapy. Dr. Lizza Hendricks, Assistant Professor at research institute GROW, School for Oncology and Developmental Biology of Maastricht University in the Netherlands. Her focus area is thoracic oncology, in particular prevention and optimal treatment of brain metastases in lung cancer and targeted therapy. Since 2019, Dr Hendriks has coordinated the clinical lung cancer research of the lung diseases department in Maastricht.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

IASLC RET NSCLC

0:00 34:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 34 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on February 22, 2023.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.